Search

everythinglearnresearchcommunity

for

Search:↓

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

PRF is preferred for better healing in dental surgeries.

Androgen receptor abnormalities may contribute to hair loss in androgenetic alopecia.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

CE-PTG is a better method for analyzing hair growth in androgenetic alopecia.

PRP significantly boosts hair growth in androgenic alopecia patients.

Combining microneedling with glycosaminoglycan lotion may improve hair growth in mild androgenetic alopecia.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

No link between hair loss and blood groups or Rhesus factor.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Minoxidil, finasteride, and PRP are the most effective and accessible treatments for male pattern hair loss.

Treat androgenetic alopecia early with recommended medications or consider hair grafts and wigs if unresponsive.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Combining β-sitosterol nanoparticles with laser therapy may effectively stimulate hair growth in androgenetic alopecia.

PRP therapy may help reduce hair loss and increase hair density in androgenetic alopecia.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Minoxidil can reduce functions related to androgen receptors.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Androgenetic alopecia is common hair loss caused by genetics and hormones.